FORGOT YOUR DETAILS?

Reading Time: 2 minutes

A paper out in the Journal of Nutrition raises an interesting notion that augmentation of Fluoextine in paediatric patients may well enhance the clinical outcomes. Putting aside for one moment the increasing challenges faced by anti-depressants to be validated as a worthwhile therapy in mild to moderate depression, plus their numerous side effect it raises an interesting possibility.[1] A safe oral supplement of ascorbates may either biochemically or circumstantially enhance recovery in young patients and that is something worth considering.[2]

Tagged under: , ,
TOP